1
|
Giambona A, Leto F, Cassarà F, Tartaglia V, Campisi R, Campisi C, Cigna V, Mugavero E, Cucinella G, Orlandi E, Picciotto F, Maggio A, Vinciguerra M. Celocentesis for Early Prenatal Diagnosis in Couples at-Risk for β-Thalassemia and Sicilian (δβ) 0-Thalassemia. Hemoglobin 2022; 46:297-302. [PMID: 36876862 DOI: 10.1080/03630269.2023.2167659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/25/2023]
Abstract
The procedures commonly used for prenatal diagnosis (PND) of thalassemia are villocentesis or amniocentesis, respectively, at the 11th and 16th weeks of gestation. Their main limitation is essentially due to the late gestation week in which diagnosis is performed. The celomic cavity is accessible between the 7th and 9th weeks of gestation and it has been demonstrated that it contains embryonic erythroid precursor cells as a source of fetal DNA for earlier invasive PND of thalassemia and other monogenic diseases. In this study, we report the use of celomatic fluids obtained from nine women with high-risk pregnancies for Sicilian (δβ)0-thalassemia [(δβ)0-thal] deletion (NG_000007.3: g.64336_77738del13403) and β-thalassemia (β-thal). Fetal cells were isolated by a micromanipulator, and nested polymerase chain reaction (PCR) and short tandem repeats (STRs) analysis were performed. Prenatal diagnosis was successfully performed in all examined cases. One fetus was a compound heterozygote for (δβ)0- and β-thal, three fetuses were found to be carriers of β-thal, four fetuses carriers of a Sicilian δβ deletion, and one fetus without parental mutations. Accidentally, a rare case of paternal triploidy was observed. The genotypic analysis, carried out both by amniocentesis and on abortive tissue or after birth, showed concordance with results obtained on fetal celomic DNA. Our results unequivocally show that fetal DNA can be obtained by nucleated fetal cells present in the celomatic fluid and demonstrate, for the first time, that PND of Sicilian (δβ)0-thal and β-thal is feasible at an earlier time in pregnancy than other procedures.
Collapse
Affiliation(s)
- Antonino Giambona
- Unit of Molecular Diagnostics of Rare Hematological Diseases, A.O.O.R. "Villa Sofia Cervello", Palermo, Italy
| | - Filippo Leto
- Unit of Molecular Diagnostics of Rare Hematological Diseases, A.O.O.R. "Villa Sofia Cervello", Palermo, Italy
| | - Filippo Cassarà
- Unit of Molecular Diagnostics of Rare Hematological Diseases, A.O.O.R. "Villa Sofia Cervello", Palermo, Italy
| | - Viviana Tartaglia
- Unit of Molecular Diagnostics of Rare Hematological Diseases, A.O.O.R. "Villa Sofia Cervello", Palermo, Italy
| | | | | | - Valentina Cigna
- Unit of Fetal Medicine and Prenatal Diagnosis, A.O.O.R. "Villa Sofia Cervello", Palermo, Italy
| | - Elena Mugavero
- Unit of Fetal Medicine and Prenatal Diagnosis, A.O.O.R. "Villa Sofia Cervello", Palermo, Italy
| | - Gaspare Cucinella
- Unit of Fetal Medicine and Prenatal Diagnosis, A.O.O.R. "Villa Sofia Cervello", Palermo, Italy
| | - Emanuela Orlandi
- Unit of Fetal Medicine and Prenatal Diagnosis, A.O.O.R. "Villa Sofia Cervello", Palermo, Italy
| | - Francesco Picciotto
- Unit of Fetal Medicine and Prenatal Diagnosis, A.O.O.R. "Villa Sofia Cervello", Palermo, Italy
| | - Aurelio Maggio
- Unit of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Laboratory for Molecular Diagnosis and Rare Hematological Diseases, A.O.O.R. "Villa Sofia Cervello", Palermo, Italy
| | - Margherita Vinciguerra
- Unit of Molecular Diagnostics of Rare Hematological Diseases, A.O.O.R. "Villa Sofia Cervello", Palermo, Italy
| |
Collapse
|
2
|
Giambona A, Vinciguerra M, Leto F, Cassarà F, Tartaglia V, Cigna V, Orlandi E, Picciotto F, Al Qahtani NH, Alsulmi ES, Almandil NB, AbdulAzeez S, Borgio JF, Maggio A. Celomic Fluid: Laboratory Workflow for Prenatal Diagnosis of Monogenic Diseases. Mol Diagn Ther 2022; 26:239-252. [PMID: 35175567 DOI: 10.1007/s40291-022-00577-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/04/2022] [Indexed: 11/29/2022]
Abstract
BACKGROUND Celomic fluid can be considered as an ultra-filtrate of maternal serum, containing a high protein concentration, urea, and many other molecules. It is an important transfer interface and a reservoir of nutrients for the embryo. Celomic fluid contains fetal cells that can be used for prenatal diagnosis of monogenic diseases in an earlier gestational period than villocentesis and amniocentesis. OBJECTIVE The purpose of this study was to evaluate the characteristics of celomic fluid and to establish a workflow laboratory procedure for very early prenatal diagnosis of monogenic diseases. METHODS Three hundred and eighty-five celomatic fluids were collected between the seventh and tenth week of gestation. We sampled 1 mL of celomic fluid in all cases. The embryo-fetal erythroid precursor cells were selected by the anti-CD71 microbead method or by a direct micromanipulator pick-up on the basis of their morphology. We amplified the extracted DNA using a nested polymerase chain reaction. Primers for short tandem repeat amplification were used to perform a quantitative fluorescent polymerase chain reaction evaluation to control maternal contamination. RESULTS We observed maternal contamination in 95% of celomic fluids with a range between 5 and 100%. No fetal cells were observed in 0.78% of celomic fluids. The number of fetal cells ranged from a few units to several hundred. Isolation of embryo-fetal erythroblasts selected by the micromanipulator made diagnosis feasible in all cases. CONCLUSIONS The selection of fetal cells by a micromanipulator and nested polymerase chain reaction analysis made celomatic fluid suitable for early prenatal diagnosis of monogenic disorders even in the presence of high maternal contamination and few fetal cells. The procedure reported in this study provides the opportunity for the use of celomic fluid sampled by celocentesis as an alternative to chorionic villi sampling and amniocentesis, to allow invasive prenatal diagnosis at a very early stage of pregnancy.
Collapse
Affiliation(s)
- Antonino Giambona
- Unit of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Laboratory for Molecular Diagnosis, and Rare Hematological Diseases, Azienda Ospedaliera, Ospedali Riuniti Villa Sofia Cervello, Via Trabucco 180, 90146, Palermo, Italy.
| | - Margherita Vinciguerra
- Unit of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Laboratory for Molecular Diagnosis, and Rare Hematological Diseases, Azienda Ospedaliera, Ospedali Riuniti Villa Sofia Cervello, Via Trabucco 180, 90146, Palermo, Italy
| | - Filippo Leto
- Unit of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Laboratory for Molecular Diagnosis, and Rare Hematological Diseases, Azienda Ospedaliera, Ospedali Riuniti Villa Sofia Cervello, Via Trabucco 180, 90146, Palermo, Italy
| | - Filippo Cassarà
- Unit of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Laboratory for Molecular Diagnosis, and Rare Hematological Diseases, Azienda Ospedaliera, Ospedali Riuniti Villa Sofia Cervello, Via Trabucco 180, 90146, Palermo, Italy
| | - Viviana Tartaglia
- Unit of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Laboratory for Molecular Diagnosis, and Rare Hematological Diseases, Azienda Ospedaliera, Ospedali Riuniti Villa Sofia Cervello, Via Trabucco 180, 90146, Palermo, Italy
| | - Valentina Cigna
- Unit of Fetal Medicine and Prenatal Diagnosis, Azienda Ospedaliera, Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Emanuela Orlandi
- Unit of Fetal Medicine and Prenatal Diagnosis, Azienda Ospedaliera, Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Francesco Picciotto
- Unit of Fetal Medicine and Prenatal Diagnosis, Azienda Ospedaliera, Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Nourah H Al Qahtani
- Obstetrics and Gynecology Department, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
| | - Eman S Alsulmi
- Obstetrics and Gynecology Department, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
| | - Noor B Almandil
- Department of Clinical Pharmacy Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
| | - Sayed AbdulAzeez
- Department of Genetic Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
| | - J Francis Borgio
- Department of Genetic Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
| | - Aurelio Maggio
- Unit of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Laboratory for Molecular Diagnosis, and Rare Hematological Diseases, Azienda Ospedaliera, Ospedali Riuniti Villa Sofia Cervello, Via Trabucco 180, 90146, Palermo, Italy
| |
Collapse
|
3
|
Giambona A, Vinciguerra M, Leto F, Cassarà F, Cucinella G, Cigna V, Orlandi E, Piccione M, Picciotto F, Maggio A. Very early prenatal diagnosis of Cockayne's syndrome by coelocentesis. J OBSTET GYNAECOL 2022; 42:1524-1531. [PMID: 35006018 DOI: 10.1080/01443615.2021.2014429] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Cockayne's syndrome (CS) is a rare autosomal recessive multisystem disease characterised by early severe progression of symptoms. This study reports the feasibility of earlier prenatal diagnosis of CS by coelocentesis at 8 weeks of gestation respect to amniocentesis or villocentesis. Three couples at risk for CS asked to perform prenatal diagnosis by coelocentesis. Coelomic fluid was aspired from coelomic cavity in four singleton pregnancy at 8 weeks of gestation and 40 foetal cells were recovered by micromanipulator. Maternal DNA contamination was evaluated by quantitative fluorescent PCR (QF-PCR) and target regions of foetal DNA containing parental mutations of ERCC6 gene were amplified and sequenced. In all these cases, molecular analysis was possible. One foetus resulted affected of CS and the diagnosis was confirmed on placental tissue after voluntary abortion. In three cases, foetuses resulted carrier of a parental mutation and the results were confirmed after the birth. This study suggests that reliable prenatal diagnosis of CS could be performed using foetal cells present in coelomatic fluid in earlier pregnancy. Coelocentesis could be applied in prenatal diagnosis of CSs as well as for other monogenic diseases, at very early stage of pregnancy, if parental mutations are already known.Impact StatementWhat is already know on this subject? Previous studies utilising coelocentesis for prenatal determination of foetal sex reported variable success ranging from 58% to 95%, because of low total DNA content and presence of maternal cell contamination. This procedure has never been reported for early prenatal diagnosis at 8 weeks of gestation for rare genetically transmitted diseases such as Cockayne's syndrome.What do the results of this study add? This study demonstrates that coelomic fluid sampling combined with well-standardised laboratory procedures can be applied for prenatal diagnosis at eight weeks of gestation for any rare monogenic disease if molecular defects are known.What are the implications of these findings for clinical practice and/or further research? The findings of this study in at risk couples for monogenic diseases investigated by coelocentesis demonstrate that embryo-foetal cell selection from CF allows reliable and early prenatal diagnosis of diseases. This technique is attractive to parents because it provides prenatal diagnosis of genetic disease at least 4 weeks earlier than what can be achieved by the traditional procedures reducing anxiety of parents and provides the option for medical termination of affected cases at 8-10 weeks' gestation, which is less traumatic and safer than second-trimester surgical termination. Further research concerns the possibility to obtain foetal karyotype at eight weeks of gestation and the possibility of intrauterine corrective therapy.
Collapse
Affiliation(s)
- Antonino Giambona
- Unit of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Laboratory for Molecular Diagnosis of Rare Hematological Diseases, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Margherita Vinciguerra
- Unit of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Laboratory for Molecular Diagnosis of Rare Hematological Diseases, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Filippo Leto
- Unit of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Laboratory for Molecular Diagnosis of Rare Hematological Diseases, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Filippo Cassarà
- Unit of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Laboratory for Molecular Diagnosis of Rare Hematological Diseases, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Gaspare Cucinella
- Unit of Obstetrical and Gynecology, Fetal Medicine and Prenatal Diagnosis, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Valentina Cigna
- Unit of Obstetrical and Gynecology, Fetal Medicine and Prenatal Diagnosis, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Emanuela Orlandi
- Unit of Obstetrical and Gynecology, Fetal Medicine and Prenatal Diagnosis, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Maria Piccione
- Unit of Medical Genetics, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Francesco Picciotto
- Unit of Obstetrical and Gynecology, Fetal Medicine and Prenatal Diagnosis, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Aurelio Maggio
- Unit of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Laboratory for Molecular Diagnosis of Rare Hematological Diseases, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| |
Collapse
|
4
|
Makrydimas G, Damiani G, Jakil C, Cigna V, Orlandi M, Picciotto F, Schillaci G, Cassarà F, Vinciguerra M, Leto F, Giambona A, Maggio A, Nicolaides KH. Celocentesis for early prenatal diagnosis of hemoglobinopathy. ULTRASOUND IN OBSTETRICS & GYNECOLOGY : THE OFFICIAL JOURNAL OF THE INTERNATIONAL SOCIETY OF ULTRASOUND IN OBSTETRICS AND GYNECOLOGY 2020; 56:672-677. [PMID: 32339311 DOI: 10.1002/uog.22059] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Revised: 04/14/2020] [Accepted: 04/15/2020] [Indexed: 06/11/2023]
Abstract
OBJECTIVE Celocentesis is an invasive technique that can provide prenatal diagnosis of single-gene disorders, from as early as 7 weeks' gestation. The objective of this study was to examine the safety of celocentesis. METHODS In this prospective study, celocentesis was performed for prenatal diagnosis of hemoglobinopathy in 402 singleton pregnancies in which both parents were carriers of β-thalassemia or sickle cell disease trait. We assessed procedure-related maternal discomfort or pain, success of sampling and obtaining results, pregnancy outcome and postnatal follow-up. RESULTS First, celocentesis was carried out at a median gestational age of 8.6 (range, 6.9-9.9) weeks and celomic fluid was successfully aspirated in 99.8% of cases. Second, 67% of women had no or only mild discomfort, 18% had moderate discomfort, 12% had mild-to-moderate pain and 3% had severe pain. Third, prenatal diagnosis from analysis of the celomic fluid was successful in 93.8% cases, and in the last 121 cases, it was always successful. Fourth, in all cases of successful sampling and analysis of celomic fluid, the diagnosis was concordant with results obtained from additional prenatal or postnatal testing. Fifth, in addition to diagnosis of hemoglobinopathy, quantitative fluorescence polymerase chain reaction analysis, which was performed to evaluate maternal contamination using several markers for chromosomes X, Y, 21, 18 and 13, led to the accurate diagnosis of chromosomal aneuploidy. Sixth, in all cases of an affected fetus diagnosed by celocentesis in which the parents chose termination of pregnancy, this was carried out < 10 weeks' gestation. Seventh, in 97.1% (298/307) of the continuing pregnancies there was live birth, in seven (2.3%) there was miscarriage and in two (0.7%) there was loss to follow-up. Eighth, fetal abnormalities were diagnosed in three (1%) cases, including unilateral transverse amputation of the forearm, unilateral moderate hydronephrosis and small-bowel duplication. All neonates were examined by a pediatrician and were found to be phenotypically normal, except for the three cases with a prenatally diagnosed defect. CONCLUSIONS Celocentesis can be used for early prenatal diagnosis of genetic abnormalities, and the procedure-related risk of pregnancy complications appears to be low. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.
Collapse
Affiliation(s)
- G Makrydimas
- Department of Obstetrics and Gynecology, Ioannina University Hospital, Ioannina, Greece
| | - G Damiani
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - C Jakil
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - V Cigna
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - M Orlandi
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - F Picciotto
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - G Schillaci
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - F Cassarà
- Laboratory for Molecular Diagnosis of Rare Diseases, AOOR Villa Sofia Cervello, Palermo, Italy
| | - M Vinciguerra
- Laboratory for Molecular Diagnosis of Rare Diseases, AOOR Villa Sofia Cervello, Palermo, Italy
| | - F Leto
- Laboratory for Molecular Diagnosis of Rare Diseases, AOOR Villa Sofia Cervello, Palermo, Italy
| | - A Giambona
- Laboratory for Molecular Diagnosis of Rare Diseases, AOOR Villa Sofia Cervello, Palermo, Italy
| | - A Maggio
- Campus of Hematology Franco and Piera Cutino, AOOR Villa Sofia Cervello, Palermo, Italy
| | - K H Nicolaides
- Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK
| |
Collapse
|
5
|
Giambona A, Leto F, Passarello C, Vinciguerra M, Cigna V, Schillaci G, Picciotto F, Lauricella S, Nicolaides KH, Makrydimas G, Damiani G, Maggio A. Fetal aneuploidy diagnosed at celocentesis for early prenatal diagnosis of congenital hemoglobinopathies. Acta Obstet Gynecol Scand 2018; 97:312-321. [DOI: 10.1111/aogs.13287] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2017] [Accepted: 12/21/2017] [Indexed: 11/30/2022]
Affiliation(s)
- Antonino Giambona
- Unit of Hematology for Rare Diseases of the Blood and Blood-forming Organs; Laboratory for Molecular Diagnosis of Rare Diseases; Hospital Villa Sofia Cervello; Palermo Italy
| | - Filippo Leto
- Unit of Hematology for Rare Diseases of the Blood and Blood-forming Organs; Laboratory for Molecular Diagnosis of Rare Diseases; Hospital Villa Sofia Cervello; Palermo Italy
| | - Cristina Passarello
- Unit of Hematology for Rare Diseases of the Blood and Blood-forming Organs; Laboratory for Molecular Diagnosis of Rare Diseases; Hospital Villa Sofia Cervello; Palermo Italy
| | - Margherita Vinciguerra
- Unit of Hematology for Rare Diseases of the Blood and Blood-forming Organs; Laboratory for Molecular Diagnosis of Rare Diseases; Hospital Villa Sofia Cervello; Palermo Italy
| | - Valentina Cigna
- Unit of Prenatal Diagnosis; Hospital Villa Sofia Cervello; Palermo Italy
| | - Giovanna Schillaci
- Unit of Prenatal Diagnosis; Hospital Villa Sofia Cervello; Palermo Italy
| | | | | | | | - George Makrydimas
- Obstetrics and Gynecology; Ioannina University Hospital; Ioannina Greece
| | - Gianfranca Damiani
- Unit of Prenatal Diagnosis; Hospital Villa Sofia Cervello; Palermo Italy
| | - Aurelio Maggio
- Unit of Hematology for Rare Diseases of the Blood and Blood-forming Organs; Laboratory for Molecular Diagnosis of Rare Diseases; Hospital Villa Sofia Cervello; Palermo Italy
| |
Collapse
|
6
|
Giambona A, Leto F, Damiani G, Jakil C, Cigna V, Schillaci G, Stampone G, Volpes A, Allegra A, Nicolaides KH, Makrydimas G, Passarello C, Maggio A. Identification of embryo-fetal cells in celomic fluid using morphological and short-tandem repeats analysis. Prenat Diagn 2016; 36:973-978. [PMID: 27592841 DOI: 10.1002/pd.4922] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2016] [Revised: 07/21/2016] [Accepted: 08/27/2016] [Indexed: 12/17/2022]
Abstract
OBJECTIVE The main problem to wide acceptability of celocentesis as earlier prenatal diagnosis is contamination of the sample by maternal cells. The objective of this study was to investigate the cellular composition of celomic fluid for morphological discrimination between maternal and embryo-fetal cells. METHOD Celomic fluids were aspired by ultrasound-guided transcervical celocentesis at 7-9 weeks' gestation from singleton pregnancies before surgical termination for psychological reasons. DNA extracted from celomic fluid cells showed the same morphology, and quantitative fluorescent polymerase chain reaction (PCR) assay was performed to evaluate their fetal or maternal origin. RESULTS Six different types of non-hematological maternal and four different types of embryo-fetal cells were detected. The most common maternal cells were of epithelial origin. The majority of embryo-fetal cells were roundish with a nucleus located in an eccentric position near the wall. These cells were considered to be erythroblasts, probably derived from the yolk sac that serves as the initial site of erythropoiesis. CONCLUSIONS The combined use of morphology and DNA analysis makes it possible to select and isolate embryo-fetal cells, even when maternal contamination is high. This development provides the opportunity for the use of celocentesis for early prenatal diagnosis of genetic diseases and application of array comparative genomic hybridization. © 2016 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- Antonino Giambona
- Unit of Hematology for Rare Diseases of Blood and Blood-forming Organs, Regional Reference Laboratory for Screening Prenatal Diagnosis of Hemoglobinopathies, Palermo, Italy.
| | - Filippo Leto
- Unit of Hematology for Rare Diseases of Blood and Blood-forming Organs, Regional Reference Laboratory for Screening Prenatal Diagnosis of Hemoglobinopathies, Palermo, Italy
| | - Gianfranca Damiani
- Unit of Prenatal Diagnosis, Hospital Villa Sofia Cervello, Palermo, Italy
| | - Cristina Jakil
- Unit of Prenatal Diagnosis, Hospital Villa Sofia Cervello, Palermo, Italy
| | - Valentina Cigna
- Unit of Prenatal Diagnosis, Hospital Villa Sofia Cervello, Palermo, Italy
| | - Giovanna Schillaci
- Unit of Prenatal Diagnosis, Hospital Villa Sofia Cervello, Palermo, Italy
| | | | - Aldo Volpes
- Reproductive Medicine Unit, ANDROS Day Surgery Clinic, Palermo, Italy
| | - Adolfo Allegra
- Reproductive Medicine Unit, ANDROS Day Surgery Clinic, Palermo, Italy
| | - Kypros H Nicolaides
- Harris Birthright Research Centre for Fetal Medicine, King's College, London, UK
| | - George Makrydimas
- Department of Obstetrics and Gynecology, Ioannina University Hospital, Ioannina, Greece
| | - Cristina Passarello
- Unit of Hematology for Rare Diseases of Blood and Blood-forming Organs, Regional Reference Laboratory for Screening Prenatal Diagnosis of Hemoglobinopathies, Palermo, Italy
| | - Aurelio Maggio
- Unit of Hematology for Rare Diseases of Blood and Blood-forming Organs, Regional Reference Laboratory for Screening Prenatal Diagnosis of Hemoglobinopathies, Palermo, Italy
| |
Collapse
|
7
|
Giambona A, Damiani G, Leto F, Jakil C, Renda D, Cigna V, Schillaci G, Picciotto F, Nicolaides KH, Passarello C, Makrydimas G, Maggio A. Embryo-fetal erythroid cell selection from celomic fluid allows earlier prenatal diagnosis of hemoglobinopathies. Prenat Diagn 2016; 36:375-81. [DOI: 10.1002/pd.4793] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2015] [Revised: 02/08/2016] [Accepted: 02/12/2016] [Indexed: 12/14/2022]
Affiliation(s)
- Antonino Giambona
- Unit of Hematology for Rare Diseases of Blood and Blood-forming Organs; Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies; Palermo Italy
| | - Gianfranca Damiani
- Unit of Prenatal Diagnosis; Hospital Villa Sofia Cervello; Palermo Italy
| | - Filippo Leto
- Unit of Hematology for Rare Diseases of Blood and Blood-forming Organs; Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies; Palermo Italy
| | - Cristina Jakil
- Unit of Prenatal Diagnosis; Hospital Villa Sofia Cervello; Palermo Italy
| | - Disma Renda
- Unit of Hematology for Rare Diseases of Blood and Blood-forming Organs; Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies; Palermo Italy
| | - Valentina Cigna
- Unit of Prenatal Diagnosis; Hospital Villa Sofia Cervello; Palermo Italy
| | - Giovanna Schillaci
- Unit of Prenatal Diagnosis; Hospital Villa Sofia Cervello; Palermo Italy
| | | | | | - Cristina Passarello
- Unit of Hematology for Rare Diseases of Blood and Blood-forming Organs; Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies; Palermo Italy
| | - George Makrydimas
- Obstetrics and Gynecology; Ioannina University Hospital; Ioannina Greece
| | - Aurelio Maggio
- Unit of Hematology for Rare Diseases of Blood and Blood-forming Organs; Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies; Palermo Italy
| |
Collapse
|
8
|
Damiani G, Vinciguerra M, Jakil C, Cannata M, Cassarà F, Picciotto F, Schillaci G, Cigna V, Renda D, Volpes A, Sammartano F, Milone S, Allegra A, Passarello C, Leto F, Giambona A. Prenatal Diagnosis of Hemoglobinopathies: From Fetoscopy to Coelocentesis. THALASSEMIA REPORTS 2014. [DOI: 10.4081/thal.2014.2200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Prenatal diagnosis of hemoglobinopathies involves the study of fetal material from blood, amniocytes, trophoblast coelomatic cells and fetal DNA in maternal circulation. Its first application dates back to the 70s and it involves globin chain synthesis analysis on fetal blood. In the 1980s molecular analysis was introduced as well as amniocentesis and chorionic villi sampling under high-resolution ultrasound imaging. The application of direct sequencing and polymerase chain reactionbased methodologies improved the DNA analysis procedures and reduced the sampling age for invasive prenatal diagnosis from 18 to 16–11 weeks allowing fetal genotyping within the first trimester of pregnancy. In the last years, fetal material obtained at 7–8 weeks of gestation by coelocentesis and isolation of fetal cells has provided new platforms on which to develop diagnostic capabilities while non-invasive technologies using fetal DNA in maternal circulation are starting to develop.
Collapse
|
9
|
Farah R, Al Danaf J, Braiteh N, Costa JM, Farhat H, Mariani G, Giansily-Blaizot M. Life-threatening bleeding in factor VII deficiency: the role of prenatal diagnosis and primary prophylaxis. Br J Haematol 2014; 168:452-5. [PMID: 25179859 DOI: 10.1111/bjh.13106] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Roula Farah
- Department of Paediatrics, Saint George Hospital University Medical Centre, Beirut, Lebanon.
| | | | | | | | | | | | | |
Collapse
|
10
|
Pietropolli A, Vicario R, Peconi C, Zampatti S, Quitadamo MC, Capogna MV, Ragazzo M, Nardone AM, Postorivo D, Spitalieri P, Sarta S, Ratto F, Novelli G, Sangiuolo F, Piccione E, Giardina E. Transabdominal coelocentesis as early source of fetal DNA for chromosomal and molecular diagnosis. J Matern Fetal Neonatal Med 2014; 27:1656-60. [DOI: 10.3109/14767058.2013.871697] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
11
|
Giambona A, Makrydimas G, Leto F, Damiani G, Jakil MC, Picciotto F, Renda D, Fiorino R, Renda MC, Schillaci G, Gueli-Alletti D, Nicolaides KH, Maggio A. Feasibility of DNA diagnosis of haemoglobinopathies on coelocentesis. Br J Haematol 2011; 153:268-72. [DOI: 10.1111/j.1365-2141.2011.08621.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|